Giuffre Randall Michael's Form 4 filing
DiaMedica Therapeutics Inc. (DMAC) · filed Jun 26, 2023
- Accession no.
- 0001235802-23-000073
- Filed
- Jun 26, 2023
- Trade date
- Jun 23, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $254.2K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Giuffre Randall MichaelCIK 0001759822 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2023 | Voting Common Shares, no par value per share | PPurchaseAcquired | +65,000 | $3.91 | +$254,150 | 360,355 | Direct | |
| Jun 23, 2023 | Voting Common Shares, no par value per share | GGiftDisposed | −15,000 | $0.00 | $0 | 345,355 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.